To our knowledge, this is the first demonstration in prospective human study of a role for the Klotho and FGF23 serum levels at the moment of the revascularization in the development of cardiovascular complications after LER in diabetic patients with PAD and CLTI. This evidence concerns the gene KL and peripheral arterial disease.